Osteoporotic fractures: Risk assessment in clinical practice;Fractura osteoporótica: Valoración del riesgo en la práctica clínica

Medicina Clinica

Volumn 129, Issue 11, 2007, Pages 418-423

  Díaz, Mónica Vázquez ^a   Franco, Alberto López García ^b   Isasi Zaragozá, Carlos ^c   Acín, Pilar Aguado ^d  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Área 9 de Atención Primaria   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID;

BONE DENSITY; CLINICAL PRACTICE; COMMUNITY; DISEASE ASSOCIATION; ENVIRONMENT; FRAGILITY FRACTURE; HUMAN; INCIDENCE; OSTEOPOROSIS; POSTMENOPAUSE; REVIEW; RISK FACTOR; WEIGHT REDUCTION;

EID: 35348926371     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13110466     Document Type: Article

References (33)

1. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17:1237-44.
2. Nelson HD, Morris CD, Kraemer DF, Mahon S, Carney N, Nygren PM, et al. Osteoporosis in postmenopausal women: diagnosis and monitoring. Evidence Report/Technology Assessment No. 28 (Prepared by the Oregon Health & Science University Evidence-based Practice Center under Contract No. 290-97-0018). AHRQ Publication No. 01-E032. Rockville: Agency for Healthcare Research and Quality; 2001.
3. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581-9.
4. Roy DK, O'Neill TW, Finn JD, Lunt M, Silman AJ, Felsenberg D, et al; European Prospective Osteoporosis Study (EPOS). Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int. 2003;14:19-26.
5. Van Staa TP, Geusens P, Kanis JA, Leufkens HG, Gehlbach S, Cooper C. A simple clinical score for estimating the long-term risk of fracture in post-menopausal women. QJM. 2006;99:673-82.
6. Naves M, Díaz-López JB, Gómez C, Rodríguez-Rebollar A, Cannata-Andia JB. Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50. Osteoporos Int. 2005;16:2013-7.
7. Serra JA, Garrido G, Vidán M, Marañón E, Brañas F, Ortiz J. Epidemiología de la fractura de cadera en ancianos en España. An Med Interna. 2002;19:389-95.
8. Felsenberg D, Silman AJ, Lunt M, Armbrecht G, Ismail AA, Finn JD, et al. EPOS Study Group. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res. 2002;17:716-24.
9. Van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA. The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res. 2002;17:1051-6.
10. Kanis JA, Johnell O, Oden A, Sernbo I, Redlund-Johnell I, Dawson A, et al. Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int. 2000;11:669-74.
11. Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C, et al; International Osteoporosis Foundation; National Osteoporosis Foundation. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int. 2002;13:527-36.
12. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254-9.
13. De Laet CE, Van Hout BA, Burger H, Hofman A, Pols HA. Bone density and risk of hip fracture in men and women: cross sectional analysis. BMJ. 1997;315:221-5.
14. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005;20:1185-94.
15. De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330-8.
16. Lunt M, O'Neill TW, Felsenberg D, Reeve J, Kanis JA, Cooper C, et al. Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: result from the European Prospective Osteoporosis Study (EPOS). Bone. 2003;33:505-13.
17. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001;285:320-3.
18. Kanis JA, Johanson H, Oden A, Johnell O, De Late C, Eximan JA, et al. A family history of fracture and fracture risk: a meta-analysis. Bone. 2004;35:1029-37.
19. Lauritzen JB, Schwarz P, McNair P, Lund B, Transbol I. Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation. Osteoporos Int. 1993;3:133-7.
20. Mallmin H, Ljunghall S, Persson I, Naessen T, Krusemo UB, Bergstrom R. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int. 1993;52:269-72.
21. Cuddihy MT, Gabriel SE, Crowson CS, O'Fallon WM, Melton LJ III. Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int. 1999;9:469-75.
22. Gunnes M, Mellstrom D, Johnell O. How well can a previous fracture indicate a new fracture? A questionnaire study of 29,802 postmenopausal women. Acta Orthop Scand. 1998;69:508-12.
23. Van Staa TP, Leufkens HGM, Cooper C. Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporosis Int. 2002;13:624-9.
24. Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35:375-82.
25. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721-39.
26. Sociedad Española de Reumatología. Documento de Consenso 2006 sobre la osteoporosis postmenopáusica [citado 20 Oct 2006]. Disponible en: www.ser.es
27. Sociedad Española de Investigaciones óseas y metabolismo mineral-SEIOMM- Osteopororis Postmenopáusica. Guía de práctica clínica. Versión resumida [citado 1 Nov 2006]. Disponible en: www.seiomm. org/documentos/osteoporosis_es_en.pdf
28. Grupo de trabajo de menopausia y postmenopausia. Guía de práctica clínica sobre la menopausia y postmenopausia. Barcelona: Sociedad Española de Ginecología y Obstetricia, Asociación Española para el Estudio de la Menopausia, Sociedad Española de Medicina de Familia y Comunitaria y Centro Cochrane Iberoamericano; 2004.
29. Van der Klift M, De Laet CD, Pols HA. Assessment of fracture risk: who should be treated for osteoporosis? Best Pract Res Clin Rheumatol. 2005;19:937-50.
30. De Laet C, Oden A, Johansson H, Johnell O, Jonsson B, Kanis JA. The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int. 2005;16:313-8.
31. Grundy SM. Primary prevention of coronary heart disease. Integrating risk assessment with intervention. Circulation. 1999;100:988-98.
32. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. Executive summary. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24: 1601-10.
33. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al; Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344:333-40.